Episodios

  • Belzutifan: Primary Tx for Bilat Juxtapapillary Retinal Hemangioblastoma in VHL Patient
    Jul 2 2025

    On this episode of the JVRD Author's Forum podcast, Dr. Nikhil Batra of the Dartmouth School of Medicine discusses "Belzutifan as the Primary Treatment of Bilateral Juxtapapillary Retinal Hemangioblastoma in a Patient With von Hippel–Lindau Disease," published in the May/June 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Batra discuss how belzutifan, a HIF-2α inhibitor, was used off-label to successfully treat bilateral optic nerve hemangioblastomas in a patient with Von Hippel-Lindau Disease, resulting in significant tumor regression and visual improvement. Hear how this targeted therapy may represent a promising new direction in managing complex retinal tumors that are difficult to treat with traditional approaches.

    Más Menos
    11 m
  • Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study
    Jul 2 2025

    On this episode of the JVRD Author's Forum podcast, Dr. David Eichenbaum of Retina Vitreous Associates of Florida discusses "Biosimilar Ranibizumab (RaniEyes) Safety and Efficacy in the Real World: BRESER Study," published in the May/June 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Eichenbaum talk about how biosimilars are developed and approved, and why real-world data is essential for evaluating their safety and effectiveness on a large scale. Learn why cost, access, and post-market surveillance are important factors in the growing role of biosimilars in retina care.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

    Más Menos
    13 m
  • Diabetic Retinopathy Disease Burden in Patients With Lower Household Incomes vs Higher Household Incomes
    Jul 2 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Stefanie Schuman of the Duke Eye Center discusses 'Diabetic Retinopathy Disease Burden in Patients With Lower Household Incomes vs Higher Household Incomes,' published in the May/June 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Schuman discuss her study examining how household income, estimated by ZIP code, impacts the disease burden of diabetic retinopathy at presentation. Hear how socioeconomic barriers like access to care, diabetes control, and follow-up challenges contribute to worse outcomes, and why addressing social determinants of health is key to improving equity in retinal care.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

    Más Menos
    11 m
  • Postoperative Methotrexate to Reduce Reoperation Rate and Improve Vision in Patients With Complex Retinal Detachments, Advanced Diabetic Retinopathy, and Trauma
    Jun 17 2025

    In this episode of the JVRD Authors Forum, host Dr. Timothy Murray speaks with Dr. Alan Franklin of the Diagnostic and Medical Clinic in Mobile, Alabama, about his study exploring the use of postoperative methotrexate to reduce reoperation rates and improve outcomes in patients with complex retinal detachments, advanced diabetic retinopathy, and ocular trauma. Hear how real-world results sparked this investigation and why methotrexate may be a game-changer in managing proliferative vitreoretinopathy and retinal inflammation.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.


    Más Menos
    3 m
  • Adult-Onset Presentations of Retinopathy Associated With Short Telomere Syndromes
    Jun 16 2025

    On this episode of the JVRD Author’s Forum podcast, Drs. Neil M. Bressler and Kristen E. Schratz discuss 'Adult-Onset Presentations of Retinopathy Associated With Short Telomere Syndromes,' published in the May/June 2025 issue of JVRD.

    In this compelling episode, Host Dr. Timothy Murray and Drs. Bressler and Schratz of the Johns Hopkins School of Medicine explore adult-onset retinal findings linked to short telomere syndromes—conditions more commonly associated with pediatric presentations. Learn how unexplained retinal vasculopathy in two adult patients led to a deeper understanding of systemic, life-threatening disorders, and why cross-specialty collaboration is key to early diagnosis. This episode underscores the critical role of retina specialists in identifying subtle ocular signs of complex genetic diseases.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

    Más Menos
    12 m
  • Suprachoroidal Injection of Tattoo Ink
    Jun 16 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Carson C. Petrash of the University of Texas Health, San Antonio, discusses 'Suprachoroidal Injection of Tattoo Ink,' published in the May/June 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Petrash discuss a case report involving scleral tattooing and accidental suprachoroidal injection of ink. Discover how a patient narrowly avoided serious complications, what imaging revealed about the damage, and why retina specialists should be prepared to recognize and manage such body modification mishaps.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

    Más Menos
    9 m
  • Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration
    Apr 28 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. Jeffrey Heier of Ophthalmic Consultants of Boston discusses ‘Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration,' published in the March/April 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Heier discuss the clinical use of home optical coherence tomography (OCT) for managing patients with neovascular age-related macular degeneration (AMD). Dr. Heier shares study findings showing that 42% of patients would have had a different treatment decision based on home OCT monitoring, highlighting the technology’s potential to catch fluid recurrence earlier and safely extend treatment intervals, from an average of 8 weeks to over 15 weeks. They also discuss the high usability of home OCT devices, with over 95% of patients successfully setting up and using the device independently. The conversation underscores how home OCT can improve outcomes, reduce undertreatment, and drive meaningful cost savings.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

    Más Menos
    11 m
  • Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use
    Apr 28 2025

    On this episode of the JVRD Author’s Forum podcast, Dr. John Kitchens of Retina Associates of Kentucky discusses 'Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use,' published in the March/April 2025 issue of JVRD.

    Host Dr. Timothy Murray and Dr. Kitchens discuss a complex case of tractional retinal detachment initially thought to be a complication of diabetes. Despite good glycemic control (A1c 6.7), further investigation revealed the underlying cause was severe vascular damage from methamphetamine use, not diabetes. Dr. Kitchens shares insights on the importance of thorough history-taking, recognizing when clinical findings don’t align with expectations, and the value of timely surgery in achieving favorable outcomes even in complex cases.

    For more information, visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

    Más Menos
    11 m